However, studies have shown that approximately 50% of early-stage HCC patients are alpha-fetoprotein-negative, making it challenging to diagnose liver cancer accurately and promptly.[64] Similar to breast cancer, needle biopsy serves as the gold standard for diagnosing liver cancer. This evidence concerns the gene AFP and liver cancer.